Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis

IMPORTANCE: The 2019 federal Ending the HIV Epidemic initiative requires a vast expansion of access to antiretroviral therapy (ART) and preexposure prophylaxis (PrEP) for HIV treatment and prevention. However, high prices for ART and PrEP can reduce their affordability and use. Medicare covers 1 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Chien-Wen, Dudley, R. Adams, Chen, Randi, Walensky, Rochelle P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156991/
https://www.ncbi.nlm.nih.gov/pubmed/32286656
http://dx.doi.org/10.1001/jamanetworkopen.2020.2739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156991/
https://www.ncbi.nlm.nih.gov/pubmed/32286656
http://dx.doi.org/10.1001/jamanetworkopen.2020.2739

Ejemplares similares